Lipella Pharmaceuticals Inc. Operating Lease, Expense
Lipella Pharmaceuticals Inc. (LIPO) reported Operating Lease, Expense of $16.30 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-11-14
- Lipella Pharmaceuticals Inc. operating lease, expense for the quarter ending 2025-09-30 was $16.30K, a 31.59% decline year-over-year.
- Lipella Pharmaceuticals Inc. operating lease, expense for the quarter ending 2025-06-30 was $23.83K, a 0.00% change year-over-year.
- Lipella Pharmaceuticals Inc. operating lease, expense for the quarter ending 2025-03-31 was $23.61K, a 3.40% decline year-over-year.
- Lipella Pharmaceuticals Inc. operating lease, expense for the quarter ending 2024-12-31 was $25.25K, a 6.31% increase year-over-year.
- Lipella Pharmaceuticals Inc. operating lease, expense for fiscal 2024 was $96.93K, a 24.65% increase from fiscal 2023.
- Lipella Pharmaceuticals Inc. operating lease, expense for fiscal 2023 was $77.76K, a 19.96% increase from fiscal 2022.
- Lipella Pharmaceuticals Inc. operating lease, expense for fiscal 2022 was $64.82K, a 1.16% decline from fiscal 2021.
- Lipella Pharmaceuticals Inc. operating lease, expense for fiscal 2021 was $65.58K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $16.30K 10-Q · filed 2025-11-14 | $40.14K derived: sum of 2 quarters · filed 2025-11-14 | $65.11K 10-Q · filed 2025-11-14 | $89.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | $23.83K 10-Q · filed 2025-08-14 | $47.67K 10-Q · filed 2025-08-14 | $72.69K derived: sum of 3 quarters · filed 2025-08-14 | $96.53K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-03-31 | $23.61K 10-Q · filed 2025-05-14 | $48.86K derived: sum of 2 quarters · filed 2025-05-14 | $72.69K derived: sum of 3 quarters · filed 2025-11-14 | $96.53K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-12-31 | $25.25K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $49.08K derived: sum of 2 quarters · filed 2025-11-14 | $72.92K derived: sum of 3 quarters · filed 2025-11-14 | $96.93K 10-K · filed 2025-03-28 | |
| 2024-09-30 | $23.83K 10-Q · filed 2025-11-14 | $47.67K derived: sum of 2 quarters · filed 2025-11-14 | $71.68K 10-Q · filed 2025-11-14 | $95.86K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $23.83K 10-Q · filed 2025-08-14 | $47.84K 10-Q · filed 2025-08-14 | $72.02K derived: sum of 3 quarters · filed 2025-08-14 | $92.67K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $24.44K 10-Q · filed 2025-05-14 | $48.19K derived: sum of 2 quarters · filed 2025-05-14 | $68.84K derived: sum of 3 quarters · filed 2025-05-14 | $85.21K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $23.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $44.40K derived: sum of 2 quarters · filed 2025-03-28 | $60.77K derived: sum of 3 quarters · filed 2025-03-28 | $77.76K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $20.65K 10-Q · filed 2024-11-14 | $37.02K derived: sum of 2 quarters · filed 2024-11-14 | $54.01K 10-Q · filed 2024-11-14 | $53.38K 10-Q · filed 2023-11-14 | $69.10K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $16.37K 10-Q · filed 2024-08-13 | $32.74K 10-Q · filed 2024-08-13 | $48.45K derived: sum of 3 quarters · filed 2024-08-13 | $64.84K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $16.37K 10-Q · filed 2024-05-09 | $32.09K derived: sum of 2 quarters · filed 2024-05-09 | $48.48K derived: sum of 3 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $15.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $32.11K derived: sum of 2 quarters · filed 2024-02-27 | $64.82K 10-K · filed 2024-02-27 | ||
| 2022-09-30 | $16.39K 10-Q · filed 2023-11-14 | $49.10K 10-Q · filed 2023-11-14 | |||
| 2022-03-31 | $16.36K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $65.58K 10-K · filed 2023-03-31 |